Loading cancer entity…
Loading cancer entity…
Clinical trials
73 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (6)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04055220 | Efficacy and Safety of Regorafenib as Maintenance Therapy After First-line Treatment in Patients With Bone Sarcomas(REGOSTA) | recruiting | N/A | 168 | Centre Leon BerardOTHER | 1 | Feb 17, 2026 | clinicaltrials |
| NCT06387485 | A Study to Evaluate the Utilization of 3D Printed Models in Pre-Operative Planning | recruiting | N/A | 150 | Ricoh USA, Inc.INDUSTRY | 1 | Feb 6, 2026 | clinicaltrials |
| NCT05861245 | Hypofractionated Protontherapy in Chordomas and Chondrosarcomas of the Skull Base | recruiting | N/A | 20 | QuironsaludOTHER | 1 | Jan 23, 2026 | clinicaltrials |
| NCT07360964 | Clear Cell Chondrosarcoma in Italy(CIRCLE) | active not recruiting | N/A | 77 | Istituto Ortopedico RizzoliOTHER | 1 | Jan 22, 2026 | clinicaltrials |
| NCT01449149 | Proton Radiation for Chordomas and Chondrosarcomas | completed | N/A | 54 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Dec 5, 2025 | clinicaltrials |
| NCT06029218 | Analysis of the Toxicity and Efficacy of Daily 1 vs 2 Beam Proton Therapy(P1V2) | recruiting | N/A | 106 | Centre Antoine LacassagneOTHER | 1 | Sep 25, 2024 | clinicaltrials |
| NCT06526897 | Evaluation of Chest CT Versus Chest X-Ray for Lung Surveillance After Curative-Intent Resection of High-Risk Truncal-Extremity Soft Tissue Sarcoma | not yet recruiting | N/A | 1,582 | ECOG-ACRIN Cancer Research GroupNETWORK | 0 | Jul 30, 2024 | clinicaltrials |
| NCT04098887 | Lattice Stereotactic Body Radiation Therapy (Lattice SBRT) for Localized Unresectable or Metastatic Conventional Type Chondrosarcoma | withdrawn | N/A | 0 | Washington University School of MedicineOTHER | 0 | Sep 16, 2020 | clinicaltrials |
| NCT01609179 | IPI-926 Extension Protocol for Continuation of Treatment With IPI-926 | completed | N/A | 9 | Infinity Pharmaceuticals, Inc.INDUSTRY | 1 | Nov 14, 2012 | clinicaltrials |
Data updated 22 days agoSource updated Feb 17, 2026source: clinicaltrials